References

Abdool Karim, S., K. Naidoo, A. Grobler, N. Padayatchi, C. Baxter, A. Gray, T. Gengiah, G. Nair, S. Bamber, A. Singh, M. Khan, J. Pienaar, W. El-Sadr, G. Friedland, and Q. Abdool Karim. 2010. Timing of initiation of antiretroviral drugs during tuberculosis therapy. New England Journal of Medicine 362(8):697-706.

Adams, S., R. Ehrlich, R. van Zyl Smit, R. Dawson, Q. Said-Hartley, and K. Dheda. 2010. Mycobacterium tuberculosis infection in health workers at primary care facilities in the Western Cape. Paper presented at 2nd South African Tuberculosis Conference, Durban, South Africa.

Association of Public Health Laboratories and Public Health Informatics Institute. 2003. Requirements Document for Public Health Laboratory Information (LIM) Systems. Washington, DC: Association of Public Health Laboratories.

Basu, S., J. Andrews, E. Poolman, N. Gandhi, N. Shah, A. Moll, P. Moodley, A. Galvani, and G. Friedland. 2007. Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: An epidemiological modelling study. Lancet 370(9597):1500-1507.

Brust, J. C. M., N. R. Gandhi, H. Carrara, G. Osburn, and N. Padayatchi. 2010. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003. The International Journal of Tuberculosis and Lung Disease 14:413-419.

Diacon, A., A. Pym, M. Grobusch, R. Patientia, R. Rustomjee, L. Page-Shipp, C. Pistorius, R. Krause, M. Bogoshi, G. Churchyard, A. Venter, J. Allen, J. Palomino, T. De Marez, R. van Heeswijk, N. Lounis, P. Meyvisch, J. Verbeeck, W. Parys, K. de Beule, K. Andries, and D. Neeley. 2009. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. New England Journal of Medicine 360(23):2397-2405.

DoH (Department of Health, Republic of South Africa). 2007. Tuberculosis strategic plan for South Africa, 2007-2011. http://www.hst.org.za/uploads/files/tb_strategic_plan_indd.pdf (accessed September 7, 2010).



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 89
References Abdool Karim, S., K. Naidoo, A. Grobler, N. Padayatchi, C. Baxter, A. Gray, T. Gengiah, G. Nair, S. Bamber, A. Singh, M. Khan, J. Pienaar, W. El-Sadr, G. Friedland, and Q. Abdool Karim. 2010. Timing of initiation of antiretroviral drugs during tuberculosis therapy. New England Journal of Medicine 362(8):697-706. Adams, S., R. Ehrlich, R. van Zyl Smit, R. Dawson, Q. Said-Hartley, and K. Dheda. 2010. Mycobacterium tuberculosis infection in health workers at primary care facilities in the Western Cape. Paper presented at 2nd South African Tuberculosis Conference, Durban, South Africa. Association of Public Health Laboratories and Public Health Informatics Institute. 2003. Requirements Document for Public Health Laboratory Information (LIM) Systems. Washington, DC: Association of Public Health Laboratories. Basu, S., J. Andrews, E. Poolman, N. Gandhi, N. Shah, A. Moll, P. Moodley, A. Galvani, and G. Friedland. 2007. Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: An epidemiological modelling study. Lancet 370(9597):1500-1507. Brust, J. C. M., N. R. Gandhi, H. Carrara, G. Osburn, and N. Padayatchi. 2010. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003. The International Journal of Tuberculosis and Lung Disease 14:413-419. Diacon, A., A. Pym, M. Grobusch, R. Patientia, R. Rustomjee, L. Page-Shipp, C. Pistorius, R. Krause, M. Bogoshi, G. Churchyard, A. Venter, J. Allen, J. Palomino, T. De Marez, R. van Heeswijk, N. Lounis, P. Meyvisch, J. Verbeeck, W. Parys, K. de Beule, K. Andries, and D. Neeley. 2009. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. New England Journal of Medicine 360(23):2397-2405. DoH (Department of Health, Republic of South Africa). 2007. Tuberculosis strategic plan for South Africa, 2007-2011. http://www.hst.org.za/uploads/files/tb_strategic_plan_indd.pdf (accessed September 7, 2010). 89

OCR for page 89
90 DRUG-RESISTANT TUBERCULOSIS IN SOUTHERN AFRICA Drobac, P., J. Mukherjee, K. Joseph, C. Mitnick, J. Furin, H. del Castillo, S. Shin, and M. Becerra. 2006. Community-based therapy for children with multidrug-resistant tubercu- losis. Pediatrics 117(6):2022-2029. Falzon, D., M. Zignol, W. Nkhoma, W. van Gemert, A. Wright, and E. Jaramillo. 2009. An update on drug-resistant tuberculosis in Africa. Presentation at the 40th Union World Conference on Lung Health, Cancun, Mexico. Gandhi, N. R., A. Moll, A. W. Sturm, R. Pawinski, T. Govender, U. Lalloo, K. Zeller, J. Andrews, and G. Friedland. 2006. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368(9547):1575-1580. Gandhi, N. R., N. S. Shah, J. R. Andrews, V. Vella, A. P. Moll, M. Scott, D. Weissman, C. Marra, U. G. Lalloo, and G. H. Friedland, on behalf of the Tugela Ferry Care and Research (TF CARES) Collaboration. 2010. HIV coinfection in multidrug- and exten- sively drug-resistant tuberculosis results in high early mortality. American Journal of Respiratory and Critical Care Medicine 181(1):80-86. Haley, C. E., R. C. McDonald, L. Rossi, W. D. Jones Jr, R. W. Haley, and J. P. Luby. 1989. Tuberculosis epidemic among hospital personnel. Infection Control and Hospital Epide- miology 10(5):204-210. IOM (Institute of Medicine). 2009. Addressing the Threat of Drug-Resistant Tuberculosis: A Realistic Assessment of the Challenge: Workshop Summary. Washington, DC: The National Academies Press. Jarand, J., K. Shean, M. O’Donnell, M. Loveday, C. Kvasnovsky, M. van der Walt, S. Adams, P. Willcox, J. O’Grady, A. Zumla, and K. Dheda. 2010. Extensively drug-resistant tuber- culosis (XDR-TB) among health care workers in South Africa. Tropical Medicine and International Health 15(10):1179-1184. Johnson, R., R. Warren, O. Strauss, A. Jordaan, A. Falmer, N. Beyers, H. Schaaf, M. Murray, K. Cloete, P. van Helden, and T. Victor. 2006. An outbreak of drug resistant tuberculosis caused by a Beijing strain in the Western Cape, South Africa. International Journal of Tuberculosis and Lung Disease 10(12):1412-1414. Johnson, R., R. Warren, G. van der Spuy, N. Gey van Pittius, D. Theron, E. Streicher, M. Bosman, G. Coetzee, P. van Helden, and T. Victor. 2010. Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain. International Journal of Tuberculosis and Lung Disease 14:119-121. Kenyon, T. A., S. E. Valway, W. W. Ihle, I. M. Onorato, and K. G. Castro. 2009. Transmission of multidrug-resistant Mycobacterium tuberculosis during a long airplane flight. New England Journal of Medicine 334(15):933-938. Keshavjee, S., and K. Seung. 2008. Stemming the tide of multidrug-resistant tuberculosis: Major barriers to addressing the growing epidemic. http://www.brighamandwomens. org/socialmedicine/News/IOM_MDRTB_whitepaper_2009_01_14_FINAL_Edited.pdf (accessed September 7, 2010). Kvasnovsky, C. L., T. L. Dalton, J. L. Lancaster, J. D. Brand, J. P. Cegielski, and M. L. van der Walt. 2008. Early mortality among MDR- and XDR-TB patients in KwaZulu-Natal Province, South Africa. Abstract presented at 39th World IUATLD Conference, Paris, France. Kvasnovsky, C. L., J. E. Ershova, A. Borisov, K. Kurbatova, T. L. Dalton, J. Campos-Caoili, and J. P. Cegielski for PETTS (Preserving Effective TB Treatment Study) investigators. 2009. Effect of second-line drug resistance on treatment outcome among MDR TB patients in PETTS study. Abstract presented at the 40th World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease (The Union), Cancun, Mexico.

OCR for page 89
91 REFERENCES Kvasnovsky, C. L., J. P. Cegielski, R. Erasmus, N. O. Siwisa, K. Thomas, and M. L. van der Walt. 2010. High mortality in HIV-positive and HIV-negative patients with XDR-TB in Eastern Cape, South Africa. Abstract presented at the 41st World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease (The Union), Berlin, Germany. Lawn, S. D., L. Myer, L.-G. Bekker, and R. Wood. 2006. Burden of tuberculosis in an anti- retroviral treatment programme in sub-Saharan Africa: Impact on treatment outcomes and implications for tuberculosis control. AIDS 20(12):1605-1612. Lawn, S., K. Kranzer, and R. Wood. 2009. Antiretroviral therapy for control of the HIV- associated tuberculosis epidemic in resource-limited settings. Clinics in Chest Medicine 30:685-689. Lawn, S., R. Wood, K. De Cock, K. Kranzer, J. Lewis, and G. Churchyard. 2010. Com- plementary roles of antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in resource-limited settings. Lancet Infectious Diseases 10:489-498. Mac-Arthur Jr., A., S. Gloyd, P. Perdigão, A. Noya, J. Sacarlal, and J. Kreiss. 2001. Charac- teristics of drug resistance and HIV among tuberculosis patients in Mozambique. Inter- national Journal of Tuberculosis and Lung Disease 5:894-902. Maus, C. E., B. B. Plikaytis, and T. M. Shinnick. 2005. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 49(2):571-577. Mazurek, G. H., J. Jereb, A. Vernon, P. LoBue, S. Goldberg, and K. Castro. 2010. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuber- culosis infection—United States, 2010. http://www.cdc.gov/mmwr/pdf/rr/rr5905.pdf (accessed September 13, 2010). Migliori, G. B., C. Lange, E. Girardi, R. Centis, G. Besozzi, K. Kliiman, L. R. Codecasa, A. Spanevello, D. M. Cirillo, and S. T. S. Group. 2008. Fluoroquinolones: Are they essential to treat multidrug-resistant tuberculosis? European Respiratory Journal 31(4):904-905. Moll, T., N. Gandhi, A. W. Sturm, J. Andrews, N. S. Shah, U. Lalloo, P. Moodley, and G. Friedland. 2007. Extensively drug-resistant (XDR) TB now more common than MDR TB in Tugela Ferry, KwaZulu-Natal, South Africa. Abstract presented at the 38th World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease (The Union), Cape Town, South Africa. Nugent, R., E. Back, and A. Beith. 2010. The race against drug resistance: A report of the center for global development’s drug resistance working group. http://www.cgdev.org/ content/publications/detail/1424207/ (accessed August 17, 2010). Nunes, E. A., E. M. De Capitani, E. Coelho, O. A. Joaquim, I. R. O. Figueiredo, A. M. Cossa, A. C. Panunto, and M. Carvalho-Ramos. 2005. Patterns of anti-tuberculosis drug resis- tance among HIV-infected patients in Maputo, Mozambique, 2002-2003. International Journal of Tuberculosis and Lung Disease 9:494-500. O’Donnell, M., N. Padayatchi, I. Master, G. Osburn, and C. Horsburgh. 2009. Improved early results for patients with extensively drug resistant tuberculosis and HIV in South Africa. International Journal of Tuberculosis and Lung Disease 13(7):855-861. Parida, S. K., and S. H. E. Kaufmann. 2010. The quest for biomarkers in tuberculosis. Drug Discovery Today 15(3-4):148-157. Pillay, M., and A. W. Sturm. 2007. Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. Clinical Infectious Diseases 45(11):1409-1414. Riley, R., C. Mills, W. Nyka, N. Weinstock, P. Storey, L. Sultan, M. Riley, and W. Wells. 1959. Aerial dissemination of pulmonary tuberculosis: A two year study of contagion in a tuberculosis ward. American Journal of Epidemiology 142(1):3-14.

OCR for page 89
92 DRUG-RESISTANT TUBERCULOSIS IN SOUTHERN AFRICA Schaaf, H. S., P. Botha, R. P. Gie, H. A. Vermeulen, G. J. Coetzee, and P. R. Donald. 1996. The 5-year outcome of multidrug resistant tuberculosis patients in the Cape Province of South Africa. Tropical Medicine and International Health 1(5):718-722. Schaaf, H. S., K. Shean, and P. R. Donald. 2003. Culture confirmed multidrug resistant tuberculosis: Diagnostic delay, clinical features, and outcome. Archives of Disease in Childhood 88(12):1106-1111. Shean, K. 2010. Challenges Facing Health Care Workers Within the Health Systems in Which They Work. Speaker presentation at the Institute of Medicine Workshop on the Emerging Threat of Multidrug-Resistant Tuberculosis: Global and Local Challenges and Solutions, March 4, 2010, Pretoria, South Africa. Shisana, O., E. Hall, K. Maluleke, D. Stoker, C. Schwabe, M. Colvin, J. Chauveau, C. Botha, T. Gumede, H. Fomundam, N. Shaikh, T. Rehle, E. Udjo, and D. Gisselquist. 2003. The impact of HIV/AIDS on the health sector. Pretoria, South Africa: National Department of Health. Strauss, O., R. Warren, A. Jordaan, E. Streicher, M. Hanekom, A. Falmer, H. Albert, A. Trollip, E. Hoosain, P. van Helden, and T. Victor. 2008. Spread of a low-fitness drug- resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence. Journal of Clinical Microbiology 46:1514-1516. Streicher, E., R. Warren, C. Kewley, J. Simpson, N. Rastogi, C. Sola, G. van der Spuy, P. van Helden, and T. Victor. 2001. Genotypic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from rural districts of the Western Cape Province of South Africa. Journal of Clinical Microbiology (42):891-894. TBCTA (Tuberculosis Coalition for Technical Assistance). 2009. International Standards for Tuberculosis Care (ISTC), second edition. The Hague, Netherlands: TBCTA. UN (United Nations). 2010. The millennium development goals report 2010. http://www. un.org/millenniumgoals (accessed August 10, 2010). UNAIDS (Joint United Nations Programme on HIV/AIDS). 2008. 2008 report on the global AIDS epidemic. http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/2008_ Global_report.asp (accessed September 7, 2010). USAID (United States Agency for International Development). 2009. Mozambique: Tuber- culosis Profile. http://www.usaid.gov/our_work/global_health/id/tuberculosis/countries/ africa/mozambique_profile.html (accesssed December 17, 2010). van der Walt, M. L., J. L. Lancaster, K. Weyer, and P. Becker. 2007. Mortality among patients with multidrug-resistant tuberculosis (MDR TB) in South Africa. Abstract presented at the 38th World Conference on Lung Health of the International Union Against Tuber- culosis and Lung Disease (The Union), Cape Town, South Africa. van Helden, P. D. 2010. TB Diagnostics. Speaker presentation at the Institute of Medicine Workshop on The Emerging Threat of Multidrug-Resistant Tuberculosis: Global and Local Challenges and Solutions, March 4, Pretoria, South Africa. van Rie, A., R. Warren, N. Beyers, R. Gie, C. Classen, M. Richardson, S. Sampson, T. Victor, and P. van Helden. 1999. Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling “strain w” among noninstitutionalized, human immuno- deficiency virus-seronegative patients. Journal of Infectious Diseases 180:1608-1615. Victor, T., E. Streicher, C. Kewley, A. Jordaan, G. van der Spuy, M. Bosman, H. Louw, M. Murray, D. Young, P. van Helden, and R. Warren. 2007. Spread of an emerging Mycobacterium tuberculosis drug-resistant strain in the Western Cape of South Africa. International Journal of Tuberculosis and Lung Disease 11:195-201. Wells, C., J. Cegielski, L. Nelson, K. Laserson, T. Holtz, A. Finlay, K. Castro, and K. Weyer. 2007. HIV infection and multidrug resistant tuberculosis—the perfect storm. Journal of Infectious Diseases 196(S1):S86-S107.

OCR for page 89
93 REFERENCES Weyer, K., J. Lancaster, J. Brand, M. van Der Walt, and J. Levin. 2004. Survey of tuberculosis drug resistance in South Africa 2001-2002. http://www.sahealthinfo.org/tb/natsurvey.pdf (accessed September 7, 2010). WHO (World Health Organization). 2009a. Tuberculosis facts update. http://www.stoptb.org/ assets/documents/resources/factsheets/tbfactsheet_2009update_one_page.pdf (accessed September 7, 2010). WHO. 2009b. Pathways to better diagnostics for tuberculosis: A blueprint for the develop- ment of TB diagnostics by the new diagnostics working group of the Stop TB partner- ship. Geneva, Switzerland: WHO. WHO. 2010a. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. http://whqlibdoc.who.int/publications/2010/9789241599191_ eng.pdf (accessed September 7, 2010). WHO. 2010b. Global laboratory initiative. http://www.who.int/tb/dots/laboratory/gli/en/ (accessed September 7, 2010). WHO. 2010c. Antiretroviral therapy for HIV infection in adults and adolescents: Recommen- dations for a public health approach—2010 rev. Geneva, Switzerland: WHO. WHO. 2010d. Factsheet: Tuberculosis diagnostics automated DNA test. http://www.who.int/ tb/features_archive/new_rapid_test/en/index.html (accessed December 29, 2010). WHO. 2010e. Guidance on ethics of tuberculosis prevention, care and control. Geneva, Switzerland: WHO.

OCR for page 89